$MPTI

M-tron Industries, Inc. to Report Second Quarter 2026 Financial Results on August 12, 2026 and Host Conference Call on August 13, 2026

M-tron Industries, Inc. (NYSE American: MPTI) said it will report second-quarter 2026 results for the period ended June 30, 2026 after the market closes on Aug. 12, 2026. The company plans a conference call on Aug. 13, 2026 at 10:30 a.m. ET to discuss the results, with an archive on its investor site.

Original reporting
Published Aug 3, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
M-tron Industries, Inc. to Report Second Quarter 2026 Financial Results on August 12, 2026 and Host Conference Call on August 13, 2026 — source image
Decision brief

The 30-second read

$MPTINeutralMed
01

Why it matters

The primary tradable element is the earnings timing, which can increase implied volatility and drive hedging or speculative positioning ahead of the print.

02

Market read

This is a routine earnings calendar announcement, useful for planning around event risk rather than signaling a new fundamental development.

03

What to watch

Traders should focus on what management typically emphasizes in this segment (program wins, backlog, margins, and customer concentration), which is not provided here.

Relevance 4/10Novelty 3/10Timing: earnings event scheduled after the close Aug. 12, 2026, with call Aug. 13

Background

M-tron Industries is a supplier of radio frequency components and spectrum control products for aerospace and defense, avionics, and space.

Company-level read

Ticker impact

$MPTINeutralMedium confidence
Context

M-tron Industries (MPTI) will report Q2 2026 results after the close Aug. 12, 2026, and hold a call Aug. 13.

Expected impact

Likely elevated pre-earnings positioning and post-release repricing; direction depends on Q2 results versus expectations.

Evidence & confidence

The article discloses only timing (report date and call time) with no numbers or guidance, so traders mainly use it to plan around earnings risk.

Market effects

Limited, but scheduled earnings from a defense/aerospace RF components supplier can affect sentiment for niche avionics and spectrum-control supply chains.

Minimal; company operations are in Florida, South Dakota, Hong Kong, and India, but no regional macro linkage is provided.

Low; no international deal, contract, or regulatory development is mentioned.

Counterpoint

Because the release contains no new financial datapoints, the market may already price the event, reducing incremental impact beyond options positioning.

Key entities

  • M-tron Industries, Inc.

    NYSE American-listed supplier of RF components and spectrum control products.

  • Q2 2026 financial results

    Scheduled release after market close on Aug. 12, 2026.

  • Conference call

    Scheduled for Aug. 13, 2026 at 10:30 a.m. ET to review results.

Related articles

$MPTIMed

M-tron (MPTI) Industries Secures $4M Defense Contract

M-tron Industries Inc. (MPTI) said it secured $4 million in production contracts from a US Department of Defense contractor to support a next-generation electronic warfare system. The order covers high-power spectrum control and other RF components. Work in Orlando, Florida runs through 2027, with production expected past 2030, according to the company.

$APPMed

AppLovin Revenue Jumped 53%. So Why Did the Stock Just Plunge 20%?

AppLovin reported Q2 revenue of $1.92B, up 53% but slightly below the $1.94B analyst consensus, citing slower AI model improvement. Adjusted EPS rose 57% to $3.76 and adjusted EBITDA rose 58% to $1.6B. Free cash flow was $863.3M in Q2. Q3 revenue guidance was $2.055B-$2.085B. The stock fell about 20% after the results.

$AHCOHighAI 9/10

Why AdaptHealth Stock Plummeted This Week

AdaptHealth (NASDAQ: AHCO) shares fell about 47% this week after the company reported Q2 results below expectations and issued sharply lower guidance. Analysts expected EPS of $0.15; AdaptHealth posted a loss of $1.07 per share. Sales rose 12.7% to $740.3M but missed forecasts. Full-year sales guidance was cut to $2.85B-$2.89B and EBITDA and FCF ranges were reduced.

$WMSMed

Advanced Drainage Systems Q1 Earnings Call Highlights

Advanced Drainage Systems (NYSE:WMS) reported Q1 growth in stormwater storage, with the stormwater storage category up 18% and residential sales up 29% (primarily NDS). Management said NDS contributed $95 million in quarterly sales. The company maintained FY2027 outlook: net sales $3.35B to $3.55B and adjusted EBITDA $1.0B to $1.05B, with Q2 margin expected to decline.

$WPPMed

WPP H1 Earnings Call Highlights

WPP plc (NYSE:WPP) reported H1 headline operating profit of £398m (8.4% margin) and said headline diluted EPS fell to £0.151 from £0.20. Net debt was £2.9bn. The board declared an interim dividend of £0.075/share. For 2H, WPP expects like-for-like revenue less pass-through costs to decline low to mid-single digits and keeps 12% to 13% margin guidance.

$WTSMedAI 8/10

Watts Water Technologies Q2 Earnings Call Highlights

Watts Water Technologies (NYSE:WTS) raised its data center served addressable market estimate to about $2 billion from over $1 billion, citing broader global demand and liquid-cooling adoption. Q2 adjusted EBITDA rose 15% to $177 million. Watts lifted full-year organic sales growth to 8% to 11% and reported sales to 14% to 17%.